BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

791 related articles for article (PubMed ID: 18383235)

  • 1. Prebiotics, synbiotics and inflammatory bowel disease.
    Steed H; Macfarlane GT; Macfarlane S
    Mol Nutr Food Res; 2008 Aug; 52(8):898-905. PubMed ID: 18383235
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Is there any place for alimentary probiotics, prebiotics or synbiotics, for patients with inflammatory bowel disease?
    Seksik P; Dray X; Sokol H; Marteau P
    Mol Nutr Food Res; 2008 Aug; 52(8):906-12. PubMed ID: 18384087
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evidence for the use of probiotics and prebiotics in inflammatory bowel disease: a review of clinical trials.
    Hedin C; Whelan K; Lindsay JO
    Proc Nutr Soc; 2007 Aug; 66(3):307-15. PubMed ID: 17637082
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Gut microflora: a new target for therapeutic approaches in inflammatory bowel disease.
    Mitsuyama K; Sata M
    Expert Opin Ther Targets; 2008 Mar; 12(3):301-12. PubMed ID: 18269340
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inflammatory bowel disease: current insights into pathogenesis and new therapeutic options; probiotics, prebiotics and synbiotics.
    Geier MS; Butler RN; Howarth GS
    Int J Food Microbiol; 2007 Apr; 115(1):1-11. PubMed ID: 17137666
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inflammatory bowel disease, gut bacteria and probiotic therapy.
    Reiff C; Kelly D
    Int J Med Microbiol; 2010 Jan; 300(1):25-33. PubMed ID: 19800289
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Food-based strategies to modulate the composition of the intestinal microbiota and their associated health effects.
    Bosscher D; Breynaert A; Pieters L; Hermans N
    J Physiol Pharmacol; 2009 Dec; 60 Suppl 6():5-11. PubMed ID: 20224145
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prebiotics in inflammatory bowel diseases.
    Guarner F
    Br J Nutr; 2007 Oct; 98 Suppl 1():S85-9. PubMed ID: 17922967
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prebiotics, probiotics and helminths: the 'natural' solution?
    Guarner F
    Dig Dis; 2009; 27(3):412-7. PubMed ID: 19786773
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Beneficial Effects of Probiotics, Prebiotics, Synbiotics, and Psychobiotics in Inflammatory Bowel Disease.
    Wasilewski A; Zielińska M; Storr M; Fichna J
    Inflamm Bowel Dis; 2015 Jul; 21(7):1674-82. PubMed ID: 25822014
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Review article: prebiotics in the gastrointestinal tract.
    Macfarlane S; Macfarlane GT; Cummings JH
    Aliment Pharmacol Ther; 2006 Sep; 24(5):701-14. PubMed ID: 16918875
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Probiotics, prebiotics and antibiotics in inflammatory bowel disease.
    Cummings JH; Kong SC
    Novartis Found Symp; 2004; 263():99-111; discussion 111-4, 211-8. PubMed ID: 15669637
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Modulation of the microbial ecology of the human colon by probiotics, prebiotics and synbiotics to enhance human health: an overview of enabling science and potential applications.
    Rastall RA; Gibson GR; Gill HS; Guarner F; Klaenhammer TR; Pot B; Reid G; Rowland IR; Sanders ME
    FEMS Microbiol Ecol; 2005 Apr; 52(2):145-52. PubMed ID: 16329901
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Probiotics, prebiotics and symbiotics in inflammatory bowel diseases: state-of-the-art and new insights.
    Sinagra E; Tomasello G; Cappello F; Leone A; Cottone M; Bellavia M; Rossi F; Facella T; Damiani P; Zeenny MN; Damiani F; Abruzzo A; Damiano G; Palumbo VD; Cocchi M; Jurjus A; Spinelli G; Lo Monte AI; Raimondo D
    J Biol Regul Homeost Agents; 2013; 27(4):919-33. PubMed ID: 24382173
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Anti-carcinogenicity of probiotics and prebiotics.
    Burns AJ; Rowland IR
    Curr Issues Intest Microbiol; 2000 Mar; 1(1):13-24. PubMed ID: 11709850
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Role of prebiotics, probiotics, and synbiotics in management of inflammatory bowel disease: Current perspectives.
    Roy S; Dhaneshwar S
    World J Gastroenterol; 2023 Apr; 29(14):2078-2100. PubMed ID: 37122604
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Aetiology of inflammatory bowel disease (IBD): role of intestinal microbiota and gut-associated lymphoid tissue immune response.
    Thompson-Chagoyán OC; Maldonado J; Gil A
    Clin Nutr; 2005 Jun; 24(3):339-52. PubMed ID: 15896420
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Probiotics, prebiotics, synbiotics: ecological treatment for inflammatory bowel disease?
    Marteau P
    Gut; 2006 Dec; 55(12):1692-3. PubMed ID: 17124152
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Indications and challenges of probiotics, prebiotics, and synbiotics in the management of arthralgias and spondyloarthropathies in inflammatory bowel disease.
    Karimi O; Peña AS
    J Clin Gastroenterol; 2008 Sep; 42 Suppl 3 Pt 1():S136-41. PubMed ID: 18806706
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Therapies aimed at the gut microbiota and inflammation: antibiotics, prebiotics, probiotics, synbiotics, anti-inflammatory therapies.
    Quigley EM
    Gastroenterol Clin North Am; 2011 Mar; 40(1):207-22. PubMed ID: 21333908
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 40.